Extracellular phenotype of CD56+ILC1-like cells compared to previously published NK development stage phenotypes
| Marker . | S3 . | S4a . | S4b . | S5 . | CD56+ ILC1-like . |
|---|---|---|---|---|---|
| CD16 | − | − | − | + | − |
| CD56 | +/− | + | + | + | + |
| CD127 | + | +/− | Low/− | − | + |
| c-KIT | + | +/− | +/− | +/− | − |
| CD94 | − | + | + | +/− | + |
| NKG2A | − | + | + | + | + |
| NKG2C | − | − | +/− | +/− | +/− |
| NKG2D | − | + | + | + | + |
| KIR2D | − | − | − | + | − |
| NKp80 | − | − | + | + | + |
| CXCR3 | − | +/− | + | + | + |
| CD122 | − | + | + | + | + |
| Perforin | − | − | + | + | + |
| Granzyme A | − | − | +/− | + | + |
| Granzyme B | − | − | +/− | +/− | + |
| Granzyme K | − | − | + | + | + |
| Marker . | S3 . | S4a . | S4b . | S5 . | CD56+ ILC1-like . |
|---|---|---|---|---|---|
| CD16 | − | − | − | + | − |
| CD56 | +/− | + | + | + | + |
| CD127 | + | +/− | Low/− | − | + |
| c-KIT | + | +/− | +/− | +/− | − |
| CD94 | − | + | + | +/− | + |
| NKG2A | − | + | + | + | + |
| NKG2C | − | − | +/− | +/− | +/− |
| NKG2D | − | + | + | + | + |
| KIR2D | − | − | − | + | − |
| NKp80 | − | − | + | + | + |
| CXCR3 | − | +/− | + | + | + |
| CD122 | − | + | + | + | + |
| Perforin | − | − | + | + | + |
| Granzyme A | − | − | +/− | + | + |
| Granzyme B | − | − | +/− | +/− | + |
| Granzyme K | − | − | + | + | + |
+, expression of the marker; −, no expression of the marker; Low, low expression of the marker.